Formulation development of intermediate release Nimesulide tablets by CCRD for IVIVC studies

Journal Title: Pakistan Journal of Pharmaceutical Sciences - Year 2014, Vol 27, Issue 4

Abstract

 Simple and cost effective study consisting of three steps, comparison of micromeritic properties of different blends i.e. placebo without API and Nimesulide containing, Use of central composite design (CCRD) for intermediate release Nimesulide tablets and stability results of three selected Nimesulide tablet formulations which were calculated by using R Gui. Different concentrations of Avicel, hydroxypropyl methyl cellulose (HPMC) and magnesium stearate were used as variables in central composite design and two types blend i.e., with or without Nimesulide were selected for bulk density, tap density, percentage compressibility; angle of repose and Hausner’s ratio. Blending rate constant was performed after applying the different mixing times like 3, 6, 9 and 12 minutes. Twenty intermediate release formulations were designed and three formulations were chosen for compression by direct compression method on the basis of compressibility index. Physicochemical properties and best release pattern in four hours in different dissolution medium were successfully measured. Relative densities, porosity of tablets were compared with tensile strength of tablet and weight variation, hardness, friability and dissolution was performed by simple experiments. Presence of Nimesulide in the bulk increased all micromeratic tests while 9 minutes was best mixing time. The hardness of NM containing tablets increased with the increase of relative density. The release pattern was further analyzed by model dependent i.e. zero order, first order and Higuchi, Korse-meyer and Pappas, Hixson Crowell and model independent kinetic model i.e., f2 value respectively. R Gui explained the F16 formulation shows the best result in stability studies with shelf life 72 months.

Authors and Affiliations

Muhammad Hanif , Muhammad Harris Shoaib , Rabia Ismail Yousuf , Shahnila Sattar , Muhammad Nadeem , Liaqat Hussain , Muhammad Usman Zia , Iyad Naeem Muhammad , Muhammad Uzair , Imran Qadir

Keywords

Related Articles

 Apoptotic and antioxidant activities of methanol extract of Mussaenda roxburghii leaves

 Present research work was designed to study the anticancer and antioxidant activities of methanol extract of Mussaenda roxburghii. Anticancer activity of MMR has been carried out on Ehrlich ascites carcinoma (EAC)...

 Research on return visit and investigation of the relapse rate of children allergic purpura after treatment

 This paper aimed to research on return visit and investigation of the relapse rate of children allergic purpura after treatment. Children with allergic purpura were divided into two groups. The treatment group was...

 Anti-HIV-1 activities of extracts and phenolics from Smilax china L.

 Four extracts (EtOH, CHCl3, EtOAc, and BuOH) and five phenolics (dihydrokaempferol (1), resveratrol (2), kaempferol-7-O-β-D-glucoside (3), dihydrokaempferol-3-O-α-L-rhamnoside (4), oxyresveratrol (5)) from Smilax c...

 Design of a microbial contamination detector and analysis of error sources in its optical path

 Microbial contamination is a growing concern in the food safety today. To effectively control the types and degree of microbial contamination during food production, this paper introduces a design for a microbial c...

 Comprehensive review on therapeutic strategies of gouty arthritis

 Traditional medicines are practiced worldwide for treatment of gouty arthritis since ancient times. Herbs and plants always have been used in the treatment of different diseases such as gout. The present article de...

Download PDF file
  • EP ID EP94315
  • DOI -
  • Views 126
  • Downloads 0

How To Cite

Muhammad Hanif, Muhammad Harris Shoaib, Rabia Ismail Yousuf, Shahnila Sattar, Muhammad Nadeem, Liaqat Hussain, Muhammad Usman Zia, Iyad Naeem Muhammad, Muhammad Uzair, Imran Qadir (2014).  Formulation development of intermediate release Nimesulide tablets by CCRD for IVIVC studies. Pakistan Journal of Pharmaceutical Sciences, 27(4), 785-792. https://europub.co.uk/articles/-A-94315